DNLI · Denali Therapeutics Inc.

$24.40 -0.42 (-1.69%) At close · Aug 14

Market Cap

$3.90B

159.85M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-06	2026-06-30
8-K	2026-08-06	—
8-K	2026-07-28	2026-07-27
Investor Event Transcript	2026-06-30	—
8-K	2026-06-18	2026-06-12
Investor Event Transcript	2026-06-04	2026-06-30
8-K	2026-06-04	2026-06-03
8-K	2026-05-22	2026-05-21
8-K	2026-05-07	—
10-Q	2026-05-07	2026-03-31
DEF 14A	2026-04-21	2025-12-31
8-K	2026-04-03	—
8-K	2026-03-31	2026-03-27
8-K	2026-03-25	—
8-K	2026-02-26	—
10-K	2026-02-26	2025-12-31
8-K	2026-01-06	—
8-K	2025-12-10	2025-12-09
8-K	2025-12-04	—
8-K	2025-12-04	—
8-K	2025-11-06	—
10-Q	2025-11-06	2025-09-30
8-K	2025-10-14	2025-10-13
10-Q	2025-08-11	2025-06-30
8-K	2025-08-11	—
8-K	2025-07-07	—
8-K	2025-06-03	—
10-Q	2025-05-06	2025-03-31
8-K	2025-05-06	—
DEF 14A	2025-04-17	2024-12-31
8-K	2025-04-02	—
8-K	2025-03-05	—
10-K	2025-02-27	2024-12-31
8-K	2025-02-27	—
8-K	2025-01-13	—
8-K	2025-01-07	2025-01-06
8-K	2024-11-18	2024-11-12
8-K	2024-11-06	—
10-Q	2024-11-06	2024-09-30
8-K	2024-10-10	—
8-K	2024-08-01	—
10-Q	2024-08-01	2024-06-30
8-K	2024-05-31	—
8-K	2024-05-07	—
10-Q	2024-05-07	2024-03-31
DEF 14A	2024-04-18	2023-12-31
10-K	2024-02-28	2023-12-31
8-K	2024-02-27	—
8-K	2024-02-27	—
8-K	2024-02-16	—

Showing 1–50 of 119 filings

Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 277 filings 272 filers Visit website Investor relations